← Back to Search

Survivorship Care for Breast Cancer Survivors

N/A
Waitlist Available
Led By Kimlin Ashing-Giwa
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 months
Awards & highlights

Study Summary

This trial is testing whether survivorship care planning can help improve the quality of life in breast cancer survivors. Early results suggest it may reduce stress and improve well-being.

Who is the study for?
This trial is for breast cancer survivors living in Southern California who are post-surgery up to 18 months after active treatment for stage 0-3 breast cancer. It's open to those with a history of mild depression, anxiety, hypertension, or diabetes.Check my eligibility
What is being tested?
The study tests if survivorship care plans can improve life quality for breast cancer survivors. Participants will receive educational and counseling interventions alongside standard care and complete questionnaires assessing their well-being.See study design
What are the potential side effects?
Since the interventions involve education and counseling rather than medications, there may be minimal side effects such as emotional distress or discomfort during discussions about personal experiences with cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Adherence to SCP guidelines
Proportion of BCS accessing a SCP from their oncology provider
Other outcome measures
Develop a clinically and psychosocially responsive SCP-BCS template in English and a linguistically response bilingual version (English-Spanish)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (SCP-BCS template booklet and counseling)Experimental Treatment4 Interventions
Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Group II: Arm II (SCP-BCS template booklet)Active Control4 Interventions
Participants receive SCP-BCS template booklet and receive standard follow-up care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
quality-of-life assessment
2012
Completed Phase 3
~2780

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,264 Total Patients Enrolled
941 Trials studying Breast Cancer
1,543,866 Patients Enrolled for Breast Cancer
City of Hope Medical CenterLead Sponsor
570 Previous Clinical Trials
1,922,516 Total Patients Enrolled
42 Trials studying Breast Cancer
6,549 Patients Enrolled for Breast Cancer
Kimlin Ashing-GiwaPrincipal InvestigatorCity of Hope Medical Center
2 Previous Clinical Trials
195 Total Patients Enrolled
1 Trials studying Breast Cancer
145 Patients Enrolled for Breast Cancer

Media Library

Survivorship Care Planning Clinical Trial Eligibility Overview. Trial Name: NCT01824745 — N/A
Breast Cancer Research Study Groups: Arm I (SCP-BCS template booklet and counseling), Arm II (SCP-BCS template booklet)
Breast Cancer Clinical Trial 2023: Survivorship Care Planning Highlights & Side Effects. Trial Name: NCT01824745 — N/A
Survivorship Care Planning 2023 Treatment Timeline for Medical Study. Trial Name: NCT01824745 — N/A
~4 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top